Welcome to European Tribune. It's gone a bit quiet around here these days, but it's still going.
Display:
Oxford/AstraZeneca is a major WHO partner for delivery vaccines on its Global COVAX program

COVAX Announces additional deals to access promising COVID-19 vaccine candidates; plans global rollout starting Q1 2021 | Dec. 18, 2020 |

COVAX Announces new agreement, plans for first deliveries | Jan. 22, 2021 |

Additionally, COVAX announced that, pending WHO emergency use listings, nearly 150 million doses of the AstraZeneca/Oxford candidate are anticipated to be available in Q1 2021, via existing agreements with the Serum Institute of India (SII) and AstraZeneca.

by Oui on Wed Feb 10th, 2021 at 05:20:49 PM EST

Others have rated this comment as follows:

Display:

Occasional Series